Cargando…
Prognostic biomarkers of cervical squamous cell carcinoma identified via plasma metabolomics
Cervical cancer is the second most common female malignancy worldwide. The metabolic profile of plasma associated with the prognosis of cervical cancer remains poorly understood. In this cross-sectional study, plasma samples were collected from three groups of patients with CSCC, namely primary pati...
Autores principales: | Zhou, Huihui, Li, Qi, Wang, Tong, Liang, Hong, Wang, Yanan, Duan, Yani, Song, Min, Wang, Yaoxian, Jin, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617423/ https://www.ncbi.nlm.nih.gov/pubmed/31261558 http://dx.doi.org/10.1097/MD.0000000000016192 |
Ejemplares similares
-
Exploring metabolomics biomarkers for evaluating the effectiveness of concurrent radiochemotherapy for cervical cancers
por: Zhou, Huihui, et al.
Publicado: (2020) -
Prognosis of stage III cervical cancer: a two-way outcome study
por: Zhou, Huihui, et al.
Publicado: (2020) -
SEC61G identified as a prognostic biomarker of head and neck squamous cell carcinoma
por: Shi, Yanan, et al.
Publicado: (2021) -
Integrative Analysis of Metabolomics and Transcriptomics Data Identifies Prognostic Biomarkers Associated With Oral Squamous Cell Carcinoma
por: Zuo, Lihua, et al.
Publicado: (2021) -
Plasma Metabolomics Reveals Diagnostic Biomarkers and Risk Factors for Esophageal Squamous Cell Carcinoma
por: Yu, Mengjie, et al.
Publicado: (2022)